◆英語タイトル:Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4825
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Green Cross Cell Corp (031390) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of cord blood Cord blood that contains stem cells, which can be used to treat various diseases such as pediatric cancer, leukemia, stroke, diabetes, and liver diseases, among others. Green Cross Cell offers contract services ranging from manufacturing of the biopharmaceuticals, processing, cell storage, and consulting, to the product delivery. The company also carries out research programs targeted at the treatment of leukemia, pancreatic cancer, ovarian cancer, acquired immunodeficiency syndrome (AIDS) and glioblastoma. Green Cross Cell is headquartered in Seoul, South Korea.
Green Cross Cell Corp Key Recent Developments
Sep 14,2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors
Aug 30,2017: Green Cross Cell: Acquisition of INNO-BIZ certification
Apr 14,2017: Green Cross Cell, the launch of a colorectal cancer clinical trial
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Green Cross Cell Corp – Key Facts 5
Green Cross Cell Corp – Key Employees 6
Green Cross Cell Corp – Key Operational Employees 7
Green Cross Cell Corp – Major Products and Services 8
Green Cross Cell Corp – History 9
Green Cross Cell Corp – Company Statement 10
Green Cross Cell Corp – Locations And Subsidiaries 11
Head Office 11
Section 2 – Company Analysis 12
Company Overview 12
Green Cross Cell Corp – Business Description 13
R&D Overview 13
Green Cross Cell Corp – Corporate Strategy 14
Green Cross Cell Corp – SWOT Analysis 15
SWOT Analysis – Overview 15
Green Cross Cell Corp – Strengths 15
Green Cross Cell Corp – Weaknesses 16
Green Cross Cell Corp – Opportunities 17
Green Cross Cell Corp – Threats 18
Green Cross Cell Corp – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Green Cross Cell Corp, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Sep 14, 2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors 30
Aug 30, 2017: Green Cross Cell: Acquisition of INNO-BIZ certification 31
Apr 14, 2017: Green Cross Cell, the launch of a colorectal cancer clinical trial 32
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Green Cross Cell Corp, Key Facts 5
Green Cross Cell Corp, Key Employees 6
Green Cross Cell Corp, Key Operational Employees 7
Green Cross Cell Corp, Major Products and Services 8
Green Cross Cell Corp, History 9
Green Cross Cell Corp, Key Competitors 19
Green Cross Cell Corp, Ratios based on current share price 20
Green Cross Cell Corp, Annual Ratios 21
Green Cross Cell Corp, Annual Ratios (Cont...1) 22
Green Cross Cell Corp, Annual Ratios (Cont...2) 23
Green Cross Cell Corp, Interim Ratios 25
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Green Cross Cell Corp, Recent Deals Summary 29
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36
List of Figures
Green Cross Cell Corp, Performance Chart (2013 - 2017) 24
Green Cross Cell Corp, Ratio Charts 26
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28